Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Braz J Infect Dis ; 4(2): 61-6, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10795070

ABSTRACT

We evaluated the efficacy of oral levofloxacin (500mg/day for 7-21 days) in the treatment of 20 adults patients with community-acquired pneumonia (CAP) requiring hospitalization in an open prospective study. The microbiological cause of the pneumonia was identified in 14/20 patients using lower respiratory tract secretions obtained by bronchoscopy (12) and/or blood culture (2). Eight patients had S. pneumoniae, 2 P.aeruginosa, 1 H.influenzae, 1 S.aureus, 1 mixed S. aureus and K.pneumoniae, and 1 E.coli and Grp.D Streptococcus. All of the patients evaluated were judged to be improved or cured. Levofloxacin is an additional option as monotherapy for the treatment of CAP.


Subject(s)
Anti-Infective Agents/therapeutic use , Community-Acquired Infections/drug therapy , Levofloxacin , Ofloxacin/therapeutic use , Pneumonia, Bacterial/drug therapy , Administration, Oral , Adult , Aged , Community-Acquired Infections/etiology , Female , Humans , Male , Middle Aged , Ofloxacin/administration & dosage , Ofloxacin/adverse effects , Pneumonia, Bacterial/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...